Agios Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGIOS PHARMS INC, and what generic alternatives to AGIOS PHARMS INC drugs are available?
AGIOS PHARMS INC has one approved drug.
There are nine US patents protecting AGIOS PHARMS INC drugs.
There are one hundred and forty-nine patent family members on AGIOS PHARMS INC drugs in forty-five countries and eleven supplementary protection certificates in ten countries.
Summary for Agios Pharms Inc
International Patents: | 149 |
US Patents: | 9 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Agios Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 11,234,976 | ⤷ Sign Up | ⤷ Sign Up | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 10,632,114 | ⤷ Sign Up | ⤷ Sign Up | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 9,980,961 | ⤷ Sign Up | ⤷ Sign Up | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 10,632,114 | ⤷ Sign Up | ⤷ Sign Up | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 11,234,976 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Agios Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hong Kong | 1253727 | ⤷ Sign Up |
Japan | 2021155455 | ⤷ Sign Up |
Hungary | E032969 | ⤷ Sign Up |
Denmark | 3307271 | ⤷ Sign Up |
Costa Rica | 20170071 | ⤷ Sign Up |
Brazil | 112020010185 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Agios Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2448582 | C202330019 | Spain | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN PARTICULAR SULFATO DE MITAPIVAT; NATIONAL AUTHORISATION NUMBER: EU/1/22/1662; DATE OF AUTHORISATION: 20221109; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/22/1662; DATE OF FIRST AUTHORISATION IN EEA: 20221109 |
2448582 | LUC00306 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR MITAPIVAT SULFATE; AUTHORISATION NUMBER AND DATE: EU/1/22/1662 20221110 |
2448582 | 2390014-5 | Sweden | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR MITAPIVAT SULFATE; REG. NO/DATE: EU/1/22/1662 20221110 |
2448582 | CR 2023 00014 | Denmark | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
2448582 | CA 2023 00014 | Denmark | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
2448582 | 23C1017 | France | ⤷ Sign Up | PRODUCT NAME: MITAPIVAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE MITAPIVAT, EN PARTICULIER SULFATE DE MITAPIVAT.; REGISTRATION NO/DATE: EU/1/22/1662 20221110 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.